Followers | 17 |
Posts | 2148 |
Boards Moderated | 0 |
Alias Born | 09/08/2009 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 15, 2011 1:36:59 PM
SAN MARINO, Calif., July 14, 2011 /PRNewswire/ -- Viral Genetics, Inc. (Pinksheets: VRAL) will be holding a webcast presentation at 4:30PM Eastern Time on August 3, 2011 to discuss the company's recent results of operations and other developments in connection with its March 31, 2011 Quarterly Report and 2010 Annual Report. A link to register for the webcast will be provided in a press release prior to the presentation and will also be made available on the Company's website. Individuals are encouraged to submit questions about the company to info@viralgenetics.com for consideration for inclusion in the Q&A session following the presentation by Company President, Haig Keledjian.
The company intends to hold regular webcast presentations to discuss operations moving forward as part of an enhanced overall communications strategy. The timing of any additional presentations may differ from quarterly and annual report filing dates, depending on the pace and timing of new developments.
As part of this effort, the company has also recently added several features to its website at www.viralgenetics.com and other communications tools:
Email Signup - Individuals can now provide their name and email address on the company's website and be provided with press releases, filings, scientific publications, presentation dates, and other information on an ongoing basis.
Corporate Presentation – a PowerPoint presentation is available for download at http://www.viralgenetics.com/VG-IVSTR-Presentation-Q2-11.pptx.zip that discusses the company's pharmaceutical research programs, its VG Energy subsidiary's biofuel and agri-tech product development, future milestones, and other company information.
Corporate Fact Sheet – this 1-page summary of the company's current plans and milestones will be updated at least quarterly, and is also available to download at http://www.viralgenetics.com/ViralGenetics-FactSheet-Q2-11.pdf.
The 2010 and first quarter reports, including unaudited consolidated financial statements for the year ending December 31, 2010 and the three months ended March 31, 2011, are available at http://www.otcmarkets.com/stock/VRAL/financials.
"With so many projects moving forward simultaneously, it is more important than ever to maintain a regular flow of information to our shareholders and stakeholders," said Viral Genetics' President, Haig Keledjian.
About Viral Genetics, Inc.
San Marino, California-based Viral Genetics discovers drug therapies from two platform technologies based on over 60 patents: Metabolic Disruption (MDT) and Targeted Peptides (TPT). Founded in 1994, the biotech company is researching treatments for HIV/AIDS, Lyme Disease, Strep, Staph and drug resistant cancer. A majority-owned subsidiary, VG Energy (www.vgenergy.net), is dedicated to exploring biofuel and agricultural applications for the MDT platform. For more information, visit www.viralgenetics.com.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM